HDI – HemoDynamic Info

Who we serve

Built for organizations already paid to control blood pressure.

HDI starts where blood-pressure control is already measured, scored and rewarded.

Are you a clinician? See how NICaS fits your care team

Accountable Care Organizations (ACOs)

~680

Medicare ACOs

14.3M

beneficiaries

Required

BP control (Quality ID 236) for all MSSP ACOs

How HDI helps

  • Lift blood-pressure control across your attributed population.
  • Faster control protects the shared savings you keep.
  • Site-by-site results reported back.

Medicare Advantage Plans

35.2M

enrollees

Triple-weighted

Controlling High Blood Pressure in Star Ratings

5%

quality bonus at 4+ stars

How HDI helps

  • Support the triple-weighted blood-pressure measure.
  • Faster control for members in your networks.
  • Fewer return visits.

Integrated Delivery Systems (IDS)

639

health systems

59.7%

of US physicians employed by health systems

3 ways

paid on BP control: MIPS, their own ACOs and MA contracts

How HDI helps

  • One consistent approach in every primary-care clinic.
  • Results across employed physicians, ACOs and MA contracts.

Self-Funded Employer ASO Plans

~32M

adults with hypertension in self-funded employer plans

HDI estimate

3 in 4

controlled in about 30 days

lead study site, <140/90

~2

fewer office visits per patient

versus trial and error

Why employers choose it

  • Faster control: Members reach control sooner, with fewer medication changes.
  • Fewer visits: Fewer return visits means less time off work.
  • Easy to offer: Through your ASO carrier, TPA or benefits consultant.

OB-GYN & Women's Health Programs

Four medical societies now call for heart care at every stage of a woman's life.

On October 26, 2026, the American Heart Association, the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics and the Society for Maternal-Fetal Medicine spoke with one voice for the first time, redefining heart health for girls and women. High blood pressure runs through every stage of a woman's life, and that is exactly what NICaS helps physicians understand.

NICaS testing setup for hypertension in pregnancy
Published studies have used NICaS to measure a mother's hemodynamics during pregnancy, including preeclampsia.

The new female life stage framework · Blood pressure runs through every stage

Perimenarche · 8–15Early markers appear
Ovarian cycling · 15–44The childbearing years
Pregnancy · any stageThe heart's 'stress test'
Perimenopause · 45–51A cardiovascular turning point
Postmenopause · 51+Most heart attacks and strokes
Clinical

400,000+

US women die of heart disease and stroke each year, more than breast cancer, lung cancer and COPD combined

49% → 59%

of women 20 and older with high blood pressure, 2020 to 2050

1 in 7

US births involve hypertension, and the rate is rising

>1 in 3

maternal deaths are caused by cardiovascular conditions

3.2x

higher maternal death rate for Black mothers than White mothers

~2x

lifetime risk of heart disease and stroke after preeclampsia

Only ~60%

get blood-pressure follow-up within 6 months of a hypertensive pregnancy

Financial

$32.3B

cost of maternal complications for each year of births

$7.5B

of that from hypertension in pregnancy, including preeclampsia

$282,570

first-year care for a very premature baby after preeclampsia, vs $6,013 at term

+$9,389

added cost of each preeclampsia pregnancy for employers and private plans

Where NICaS fits

  • Pregnancy and postpartum: see the cause behind a mother's blood pressure; close the 6-month follow-up gap.
  • Midlife and beyond: hypertension in primary care, HDI's core; most heart attacks and strokes occur here, and over 80% are preventable.
  • New channel: the national Centers of Excellence for Women's Cardiovascular Care the societies are calling for.

Blood pressure runs through every stage of a woman's life. NICaS shows its cause.

NICaS is not a preeclampsia test; it shows the physician the cause behind the blood-pressure number, and the physician decides. The societies' papers are scientific statements and advisories; they do not evaluate or endorse NICaS.

For patients: Women's Heart Health

Sources: AHA, AAP, ACOG and SMFM, Circulation, Oct 26, 2026 (Presidential Advisory, Scientific Statement and Science Advisory on women's cardiovascular health); AHA 2026 forecast of women's health; CDC MMWR 2022; NCHS Health E-Stat 113; Bellamy et al., BMJ 2007; Mathematica/Commonwealth Fund 2021; Stevens et al., AJOG 2017; Li et al., Pregnancy Hypertension 2021.

Sources: CMS 2026 ACO participation; CMS MSSP; KFF 2026 MA enrollment; CMS 2026 Star Ratings; PAI/Avalere 2026; Cleland et al., Am J Med 2026. Self-funded employer figure is an HDI estimate.

Let's get your patients controlled in weeks.

Request a briefing